ALNY logo

Alnylam Pharmaceuticals (ALNY) Company Overview

Profile

Full Name:

Alnylam Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 1, 2004

Indexes:

Not included

Description:

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery, development, and commercialization of RNA interference (RNAi) methods for treating genetically inherited diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. The company's lineup of RNAi therapeutic research focuses on four strategic therapeutic areas: genetic medicines, cardiovascular and metabolic diseases, infectious liver diseases, and CNS and eye diseases. The company has developed a unique gene deactivation-based treatment complex for inherited diseases that were previously incurable. Another 10 gene therapy products are in development.

Key Details

Price

$246.00

Annual Revenue

$2.25 B(+22.97% YoY)

Annual EPS

-$2.18(+38.07% YoY)

Annual ROE

-414.62%

Beta

0.58

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 26, 25 RBC Capital
Outperform
Feb 26, 25 Needham
Buy
Feb 26, 25 Chardan Capital
Buy
Feb 25, 25 HC Wainwright & Co.
Buy
Feb 24, 25 HC Wainwright & Co.
Buy
Feb 18, 25 Canaccord Genuity
Buy
Feb 14, 25 Scotiabank
Sector Outperform
Feb 14, 25 Needham
Buy
Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 11, 25 RBC Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Alnylam Pharmaceuticals?
  • Does Alnylam Pharmaceuticals pay dividends?
  • What sector is Alnylam Pharmaceuticals in?
  • What industry is Alnylam Pharmaceuticals in?
  • What country is Alnylam Pharmaceuticals based in?
  • When did Alnylam Pharmaceuticals go public?
  • Is Alnylam Pharmaceuticals in the S&P 500?
  • Is Alnylam Pharmaceuticals in the NASDAQ 100?
  • Is Alnylam Pharmaceuticals in the Dow Jones?
  • When was Alnylam Pharmaceuticals's last earnings report?
  • When does Alnylam Pharmaceuticals report earnings?
  • Should I buy Alnylam Pharmaceuticals stock now?

What is the ticker symbol for Alnylam Pharmaceuticals?

The ticker symbol for Alnylam Pharmaceuticals is NASDAQ:ALNY

Does Alnylam Pharmaceuticals pay dividends?

No, Alnylam Pharmaceuticals does not pay dividends

What sector is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the Healthcare sector

What industry is Alnylam Pharmaceuticals in?

Alnylam Pharmaceuticals is in the Biotechnology industry

What country is Alnylam Pharmaceuticals based in?

Alnylam Pharmaceuticals is headquartered in United States

When did Alnylam Pharmaceuticals go public?

Alnylam Pharmaceuticals's initial public offering (IPO) was on June 1, 2004

Is Alnylam Pharmaceuticals in the S&P 500?

No, Alnylam Pharmaceuticals is not included in the S&P 500 index

Is Alnylam Pharmaceuticals in the NASDAQ 100?

No, Alnylam Pharmaceuticals is not included in the NASDAQ 100 index

Is Alnylam Pharmaceuticals in the Dow Jones?

No, Alnylam Pharmaceuticals is not included in the Dow Jones index

When was Alnylam Pharmaceuticals's last earnings report?

Alnylam Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Alnylam Pharmaceuticals report earnings?

The next expected earnings date for Alnylam Pharmaceuticals is May 2, 2025

Should I buy Alnylam Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions